<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2014</study_start_year><condition>KRAS and NRAS Wild-type Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Neoplasms</disease><disease>Kras And Nras Wild-type Colorectal Cancer</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2171254</full_dataset_link><location>United States</location><study_start_month>6</study_start_month><keyword>Panitumumab</keyword><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>Regorafenib + Panitumumab for Colorectal Cancers</name><description>Evaluate the safety of regorafenib and panitumumab</description><dates><creation>2014-06-15</creation></dates><accession>2171254</accession><cross_references><ClinicalTrials___gov>NCT02199223</ClinicalTrials___gov></cross_references></HashMap>